Infliximab for the treatment of orofacial Crohn's disease. Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction. A clustering of Crohn's disease in Mankato, Minnesota. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Mechanisms and modulation of intestinal epithelial repair.
Paneth cell defensins and innate immunity of the small bowel.
Prevention of relapse of Crohn's disease. Groupe d'Etudes des Affections Inflammatoires du Tube Digestif. Growth after intestinal resection for Crohn's disease in children, adolescents, and young adults. Same disease, different impact. The role of chemokines and chemokine receptors in mucosal inflammation.